Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1

L Maroldo; LM Fredrick; K Robinson-Morgan; R Trinh; TJ Podsadecki

首页> 外文期刊>Journal of the International Aids Society >Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1

【24h】

Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1

机译：洛匹那韦/利托那韦（LPV / r）在感染了不同亚型HIV-1的抗逆转录病毒患者中的疗效和安全性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the International Aids Society》 |2010年第4期|共页
作者
L Maroldo; LM Fredrick; K Robinson-Morgan; R Trinh; TJ Podsadecki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类流行病学与防疫;
关键词

相似文献

外文文献
中文文献
专利

1. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children. [J] . Rudin C, Burri M, Shen Y, The Pediatric infectious disease journal . 2008,第5期

机译：利托那韦，奈非那韦和洛匹那韦/利托那韦在经历过抗逆转录病毒治疗的HIV感染儿童中的长期安全性和有效性。
2. ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-na?ve HIV-1-infected adults [J] . C Orkin, E DeJesus, H Khanlou, Journal of the International Aids Society . 2010,第Suppla4期

机译：ARTEMIS：每日一次达那那韦/利托那韦（DRV / r）与洛匹那韦/ r（LPV / r）的每日治疗对未经HIV-1感染的成年人的192周疗效和安全性
3. ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-na?ve HIV-1-infected adults [J] . C Orkin, E DeJesus, H Khanlou, Journal of the International Aids Society . 2010,第Suppla4期

机译：ARTEMIS：每日一次达那那韦/利托那韦（DRV / r）与洛匹那韦/ r（LPV / r）的每日治疗对未经HIV-1感染的成年人的192周疗效和安全性
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Cost-Effectiveness Analysis of Nevirapine vs. Ritonavir-Boosted Lopinavir in HIV-infected Children With Peripartum Nevirapine Exposure In Resource-Constrained Areas From Payer's Perspective. [D] . Godwin, Onyeka Peter. 2014

机译：从付款人的角度来看，在资源受限地区感染了围产期尼维拉平的HIV感染儿童中，奈韦拉平vs.利托那韦促进洛匹那韦的成本-效果分析。
6. Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1 [O] . L Maroldo, LM Fredrick, K Robinson-Morgan, 2010

机译：洛匹那韦/利托那韦（LPV / r）在感染了不同亚型HIV-1的抗逆转录病毒患者中的疗效和安全性
7. Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1 [O] . L Maroldo, LM Fredrick, K Robinson-Morgan, 2010

机译：洛匹那韦/利托那韦（LPV / r）在感染了不同亚型HIV-1的抗逆转录病毒患者中的疗效和安全性

Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1

著录项

相似文献

相关主题

期刊订阅